Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.

ABSTRACT:

Background

The novel coronavirus pandemic calls for a rapid adaptation of conventional medical practices to meet the evolving needs of such vulnerable patients. People with coronavirus disease (COVID-19) may frequently require treatment with psychotropic medications, but are at the same time at higher risk for safety issues because of the complex underlying medical condition and the potential interaction with medical treatments.

Methods

In order to produce evidence-based practical recommendations on the optimal management of psychotropic medications in people with COVID-19, an international, multi-disciplinary working group was established. The methodology of the WHO Rapid Advice Guidelines in the context of a public health emergency and the principles of the AGREE statement

SUBMITTER: Ostuzzi G 

PROVIDER: S-EPMC7360478 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature